AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15106392 — intervention group
Group type: COMPARATOR
Intervention: Plush toy cat
Number of subjects: 0
Study 11297958 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (probiotic)
Number of subjects: 132
Study 11297958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 8909512 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic splenectomy
Number of subjects: 20
Study 8909512 — intervention group
Group type: COMPARATOR
Intervention: Open splenectomy
Number of subjects: 20
Study 1918562 — intervention group
Group type: EXPERIMENTAL
Intervention: More frequent empathic responses
Number of subjects: 6
Study 1918562 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestions volunteered by therapists
Number of subjects: 6
Study 1918562 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking questions by therapists
Number of subjects: 6
Study 6132085 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurotensin 13.5 pmol kg‐1 min‐1 for 30 min
Number of subjects: 5
Study 6132085 — intervention group
Group type: COMPARATOR
Intervention: Control infusions
Number of subjects: 5
Study 30590759 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 28238195 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (5 loading doses every 4 weeks until week 16, then extended to 8 weeks)
Number of subjects: 43
Study 26554774 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding (EN) group, n = 17
Number of subjects: 36
Study 26554774 — intervention group
Group type: COMPARATOR
Intervention: Control group (intravenous fluid until oral diets initiated), n = 19
Number of subjects: 36
Study 23259717 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensation group
Number of subjects: 11
Study 23259717 — intervention group
Group type: EXPERIMENTAL
Intervention: Restitution group
Number of subjects: 11
Study 23259717 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensation and restitution groups
Number of subjects: 11
Study 23259717 — intervention group
Group type: COMPARATOR
Intervention: Self-help group
Number of subjects: 11
Study 21881151 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized braking force (8.5%)
Number of subjects: 8
Study 21881151 — intervention group
Group type: COMPARATOR
Intervention: Standard braking force (4.5%)
Number of subjects: 8
Study 19562622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting preparation
Number of subjects: 143
Study 19562622 — intervention group
Group type: COMPARATOR
Intervention: Non-fasting preparation
Number of subjects: 143
Study 19562622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting preparation (in male patients)
Number of subjects: 143
Study 17591658 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ketamine (moderate and high doses)
Number of subjects: 15
Study 17591658 — intervention group
Group type: EXPERIMENTAL
Intervention: N,N-dimethyltryptamine (DMT) (moderate and high doses)
Number of subjects: 15
Study 17591658 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 15
Study 15553604 — intervention group
Group type: EXPERIMENTAL
Intervention: Cruciate-retaining total knee arthroplasty (CR TKA)
Number of subjects: 228
Study 15553604 — intervention group
Group type: COMPARATOR
Intervention: Cruciate-substituting total knee arthroplasty (CS TKA)
Number of subjects: 228
Study 11605747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors worn throughout the whole 10 months
Number of subjects: 548
Study 11605747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors with initial wearing period
Number of subjects: 548
Study 11605747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors refused to wear
Number of subjects: 548
Study 11605747 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular wearers of hip protectors
Number of subjects: 548
Study 11605747 — intervention group
Group type: EXPERIMENTAL
Intervention: Drop-outs from wearing hip protectors
Number of subjects: 548
Study 9444446 — intervention group
Group type: EXPERIMENTAL
Intervention: mibefradil 50 mg QD (titrated to 100 mg if needed)
Number of subjects: 296
Study 9444446 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 5 mg QD (titrated to 10 mg if needed)
Number of subjects: 296
Study 7926302 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin treatment
Number of subjects: 132
Study 7926302 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 132
Study 2735335 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate 1 g four times per day
Number of subjects: 26
Study 2735335 — intervention group
Group type: COMPARATOR
Intervention: cimetidine 400 mg twice daily
Number of subjects: 26
Study 2735335 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate
Number of subjects: 26
Study 2735335 — intervention group
Group type: COMPARATOR
Intervention: cimetidine
Number of subjects: 26
Study 4613534 — intervention group
Group type: EXPERIMENTAL
Intervention: Quingestanol acetate 800 mcg in Mexico
Number of subjects: 2702
Study 4613534 — intervention group
Group type: EXPERIMENTAL
Intervention: Quingestanol acetate 750 mcg in Chile and Peru
Number of subjects: 2702
Study 30428396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 30428396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 28260598 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (weekly for five consecutive weeks at predefined acupuncture points: CV-3, CV-4, LR-8, SP-6, SP-9)
Number of subjects: 68
Study 28260598 — intervention group
Group type: COMPARATOR
Intervention: Control group (late acupuncture)
Number of subjects: 68
Study 26204135 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic adjusted basal rate and carbohydrate ratio settings
Number of subjects: 37
Study 26204135 — intervention group
Group type: COMPARATOR
Intervention: Unchanged (control) settings
Number of subjects: 37
Study 26204135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms of CLC
Number of subjects: 37
Study 24136731 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA 290 (daily subcutaneous administration for 28 days)
Number of subjects: 0
Study 24136731 — intervention group
Group type: EXPERIMENTAL
Intervention: ARA 290
Number of subjects: 0
Study 24136731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21288841 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy (12-week course of clarithromycin and rifabutin)
Number of subjects: 50
Study 21288841 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see approach
Number of subjects: 50
Study 21288841 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy
Number of subjects: 50
Study 19614943 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Lifestyle Programme (ELP) targeting walking speed
Number of subjects: 41
Study 19614943 — intervention group
Group type: COMPARATOR
Intervention: Basic Lifestyle Programme (BLP) targeting total daily steps
Number of subjects: 41
Study 19614943 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ELP and BLP
Number of subjects: 41
Study 16861090 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride + Pioglitazone
Number of subjects: 91
Study 16861090 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride + Rosiglitazone
Number of subjects: 91
Study 14629093 — intervention group
Group type: EXPERIMENTAL
Intervention: Count to 10 chart
Number of subjects: 40
Study 14629093 — intervention group
Group type: COMPARATOR
Intervention: Hollister chart
Number of subjects: 40
Study 10867599 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) via novel multidose dry-powder inhaler (DPI)
Number of subjects: 27
Study 10867599 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) via conventional pressurised metered-dose inhaler (pMDI) with spacer
Number of subjects: 27
Study 10867599 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (DPI and pMDI)
Number of subjects: 27
Study 9085300 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (non-pregnant awaiting tubal ligation)
Number of subjects: 80
Study 9085300 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (non-pregnant with acute postoperative pain)
Number of subjects: 80
Study 9085300 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (pregnant awaiting elective cesarean section)
Number of subjects: 80
Study 9085300 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 (pregnant in active labor)
Number of subjects: 80
Study 9085300 — intervention group
Group type: COMPARATOR
Intervention: Pregnant groups (groups 3 and 4)
Number of subjects: 80
Study 9085300 — intervention group
Group type: COMPARATOR
Intervention: Acute postoperative pain or labor pain
Number of subjects: 80
Study 9085300 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 80
Study 8412394 — intervention group
Group type: EXPERIMENTAL
Intervention: Nottingham Health Profile (NHP)
Number of subjects: 185
Study 3531220 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (NLX; 0.08 mg/kg BW, iv)
Number of subjects: 47
Study 3531220 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH (50 micrograms, iv)
Number of subjects: 47
Study 3531220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 29135692 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ultrasonography-neurostimulation
Number of subjects: 110
Study 29135692 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guidance alone
Number of subjects: 110
Study 27170565 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment (IAT)
Number of subjects: 288
Study 27170565 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 288
Study 24421075 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-based alcohol intervention
Number of subjects: 0
Study 24421075 — intervention group
Group type: COMPARATOR
Intervention: Feedback about other health-related behaviors (control condition)
Number of subjects: 0
Study 22537732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy insomnia intervention
Number of subjects: 0
Study 22537732 — intervention group
Group type: COMPARATOR
Intervention: Traditional depression-focused treatment
Number of subjects: 0
Study 20124143 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program targeting physical activity injuries
Number of subjects: 2210
Study 20124143 — intervention group
Group type: COMPARATOR
Intervention: Regular curriculum (Control)
Number of subjects: 2210
Study 17651144 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTM1 null genotype
Number of subjects: 630
Study 17651144 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma patients
Number of subjects: 630
Study 17651144 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 630
Study 17651144 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTT1 and GSTM1 null genotypes
Number of subjects: 630
Study 16171419 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-factor representation of dispositional appraisal
Number of subjects: 0
Study 16171419 — intervention group
Group type: COMPARATOR
Intervention: 6-factor representation of dispositional appraisal
Number of subjects: 0
Study 16171419 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-factor solution
Number of subjects: 0
Study 12234860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg daily for 30 days
Number of subjects: 5
Study 10424293 — intervention group
Group type: EXPERIMENTAL
Intervention: Training sample (n=506)
Number of subjects: 761
Study 10424293 — intervention group
Group type: EXPERIMENTAL
Intervention: Test sample (n=255)
Number of subjects: 761
Study 7478808 — intervention group
Group type: EXPERIMENTAL
Intervention: Pubertal development graded into three groups according to estradiol and testosterone concentrations
Number of subjects: 354
Study 7478808 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepubertal children
Number of subjects: 354
Study 7478808 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear correlation between IGF‐I and IGFBP‐3
Number of subjects: 354
Study 2126396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustac (ST)
Number of subjects: 0
Study 2126396 — intervention group
Group type: EXPERIMENTAL
Intervention: Trinitrolong (TNL)
Number of subjects: 0
Study 2126396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2126396 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term continuous treatment with ST and TNL
Number of subjects: 0
Study 2126396 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term continuous treatment with ST
Number of subjects: 0
Study 91889 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg naloxone (intervention)
Number of subjects: 20
Study 30088217 — intervention group
Group type: EXPERIMENTAL
Intervention: RLIC
Number of subjects: 69
Study 30088217 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 69
Study 28068912 — intervention group
Group type: EXPERIMENTAL
Intervention: Soap-and-water hand wash
Number of subjects: 1270
Study 28068912 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand rub
Number of subjects: 1270
Study 28068912 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1270
Study 25531536 — intervention group
Group type: EXPERIMENTAL
Intervention: Voucher-based treatment with motivational counseling (14 days of vouchers for complete smoking abstinence after a 5-day smoking reduction lead-in period)
Number of subjects: 184
Study 25531536 — intervention group
Group type: COMPARATOR
Intervention: Voucher-based treatment with motivational counseling (vouchers not contingent on abstinence)
Number of subjects: 184
Study 25531536 — intervention group
Group type: EXPERIMENTAL
Intervention: Intolerance for Smoking Abstinence Discomfort (IDQ-S) and nicotine dependence severity (FTND)
Number of subjects: 184
Study 25531536 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment motivation to quit smoking
Number of subjects: 184
Study 25531536 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower withdrawal intolerance
Number of subjects: 184
Study 25531536 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher withdrawal intolerance pretreatment
Number of subjects: 184
Study 23884486 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200-mg tablet QD for 12 weeks
Number of subjects: 0
Study 23884486 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 100-mg capsules QD for 12 weeks
Number of subjects: 0
Study 23884486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20980196 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with round electrodes
Number of subjects: 12
Study 20980196 — intervention group
Group type: COMPARATOR
Intervention: tDCS with rectangular electrodes
Number of subjects: 12
Study 20980196 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS with round electrodes
Number of subjects: 12
Study 20980196 — intervention group
Group type: COMPARATOR
Intervention: tRNS with rectangular electrodes
Number of subjects: 12
Study 19302902 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime IV at a dose of 1 g q8h
Number of subjects: 120
Study 19302902 — intervention group
Group type: COMPARATOR
Intervention: Other appropriate antimicrobials
Number of subjects: 120
Study 19302902 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients studied
Number of subjects: 120
Study 17403273 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (10 g/d) for 21 days
Number of subjects: 12
Study 17403273 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightly cooked cabbage (microwaved for 2 min)
Number of subjects: 12
Study 17403273 — intervention group
Group type: COMPARATOR
Intervention: Control (no inulin) for 21 days
Number of subjects: 12
Study 17403273 — intervention group
Group type: COMPARATOR
Intervention: Fully cooked cabbage (microwaved for 5.5 min)
Number of subjects: 12
Study 15509187 — intervention group
Group type: EXPERIMENTAL
Intervention: fenofibrate 160 mg plus colesevelam HCl 3750 mg (6 x 625 mg tablets) administered with breakfast
Number of subjects: 30
Study 15509187 — intervention group
Group type: EXPERIMENTAL
Intervention: fenofibrate 160 mg administered with breakfast, followed 4 hours later by colesevelam HCl 3750 mg (6 x 625 mg tablets) administered with lunch
Number of subjects: 30
Study 15509187 — intervention group
Group type: COMPARATOR
Intervention: fenofibrate 160 mg administered with breakfast
Number of subjects: 30
Study 11813601 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional immunochemotherapy combined with systemic chemotherapy (Group A)
Number of subjects: 122
Study 11813601 — intervention group
Group type: COMPARATOR
Intervention: Systemic immunotherapy combined with systemic chemotherapy (Group B)
Number of subjects: 122
Study 9492130 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide/50% oxygen
Number of subjects: 30
Study 9492130 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen
Number of subjects: 30
Study 8064995 — intervention group
Group type: EXPERIMENTAL
Intervention: IINS (Insulin + Amino Acids)
Number of subjects: 32
Study 8064995 — intervention group
Group type: COMPARATOR
Intervention: ICON (Control with Amino Acids)
Number of subjects: 32
Study 8064995 — intervention group
Group type: EXPERIMENTAL
Intervention: IIINS (Insulin + Higher Nitrogen Load)
Number of subjects: 32
Study 8064995 — intervention group
Group type: COMPARATOR
Intervention: IICON (Control with Higher Nitrogen Load)
Number of subjects: 32
Study 2737711 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mmol/day calcium carbonate (CaCO3)
Number of subjects: 95
Study 2737711 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mmol/day calcium carbonate (CaCO3)
Number of subjects: 95
Study 2737711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 2737711 — intervention group
Group type: EXPERIMENTAL
Intervention: Rechallenge with 20 mmol/day CaCO3
Number of subjects: 95
Study 28544896 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 151
Study 28544896 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 151
Study 26218035 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight revised Forever Free booklets (n = 703)
Number of subjects: 1407
Study 26218035 — intervention group
Group type: COMPARATOR
Intervention: Single leaflet (n = 704)
Number of subjects: 1407
Study 24156290 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriptive dietary intervention
Number of subjects: 109
Study 20882421 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg of elemental zinc per day for 5 days)
Number of subjects: 106
Study 20882421 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (equal amount to zinc, modified for taste, smell, color, and consistency)
Number of subjects: 106
Study 20882421 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 106
Study 18235194 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized training for phonologic awareness
Number of subjects: 218
Study 18235194 — intervention group
Group type: COMPARATOR
Intervention: General perception training
Number of subjects: 218
Study 15963089 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) 0.5 mg sublingual
Number of subjects: 29
Study 15963089 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 100 mg daily for 4 days
Number of subjects: 29
Study 15963089 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental activation, standing, exercise
Number of subjects: 29
Study 12870063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous penicillin, 6 million units per day (one million unit every four hours) for seven days
Number of subjects: 253
Study 12870063 — intervention group
Group type: COMPARATOR
Intervention: Control group (without penicillin)
Number of subjects: 253
Study 12870063 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 253
Study 10571602 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone (84 mg t.d.s.)
Number of subjects: 173
Study 10571602 — intervention group
Group type: COMPARATOR
Intervention: Cisapride (10 mg t.d.s.)
Number of subjects: 173
Study 10571602 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone
Number of subjects: 173
Study 10571602 — intervention group
Group type: COMPARATOR
Intervention: Cisapride
Number of subjects: 173
Study 8712383 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI) 300,000 U infused in Groups C and D
Number of subjects: 39
Study 1905214 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition alone
Number of subjects: 97
Study 1905214 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition and sucralfate (1 g by nasogastric tube every 4 hrs)
Number of subjects: 97
Study 1905214 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition and ranitidine (50 mg iv every 6 hrs)
Number of subjects: 97
Study 1905214 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition and sucralfate
Number of subjects: 97
Study 1905214 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition and ranitidine
Number of subjects: 97
Study 6668226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate
Number of subjects: 160
Study 6668226 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate with riboflavin
Number of subjects: 160
Study 6668226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 30857773 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Triple P intervention (4 hospital-based and 4 home-phone sessions)
Number of subjects: 384
Study 30857773 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (control group)
Number of subjects: 384
Study 30131262 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (indwelling press needles)
Number of subjects: 30
Study 30131262 — intervention group
Group type: COMPARATOR
Intervention: Control (sham needles)
Number of subjects: 30
Study 26505163 — intervention group
Group type: EXPERIMENTAL
Intervention: Δ9‐THC (8 mg)
Number of subjects: 24
Study 26505163 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (5 mg/10 mg diazepam)
Number of subjects: 24